Skip to content
Home
Andrew Cameron, Ph.D.

Andrew Cameron, Ph.D.

Contact

About Me

Andrew Cameron, Ph.D., is a faculty member in the Department of Pathology and Laboratory Medicine and Assistant Director of the Clinical Microbiology Laboratories at the UR Medicine Central Laboratory. As a board-certified Clinical Microbiologist, he is a Diplomate of the American Board of Medical M...
Andrew Cameron, Ph.D., is a faculty member in the Department of Pathology and Laboratory Medicine and Assistant Director of the Clinical Microbiology Laboratories at the UR Medicine Central Laboratory. As a board-certified Clinical Microbiologist, he is a Diplomate of the American Board of Medical Microbiology.

Dr. Cameron completed his Ph.D at the University of British Columbia, Vancouver, BC, Canada, where he studied the pathogenesis and high-frequency variation of the gastrointestinal pathogen Campylobacter jejuni. He completed post-doctoral training at the University of Calgary and the Government of Canada, where he studied the genomics of bacterial pathogens. Most recently, Dr. Cameron completed a Fellowship in Medical and Public Health Microbiology at the University of Rochester Medical Center.

Faculty Appointments

Assistant Professor - Department of Pathology and Laboratory Medicine (SMD)

Credentials

Post-doctoral Training & Residency

CPEP Medical and Public Health Microbiology (American Society for Microbiology). University of Rochester Medical Center 2019 - 2021

Post-doctoral Fellowship (Natural Sciences and Engineering Research Council of Canada). University of Calgary 2016 - 2019

Post-doctoral Research Program (Agriculture and Agri-Food Canada). Government of Canada 2015 - 2019

Education

PhD | Canada - University of British Columbia. Microbiology and Immunology. 2015

BSc | Canada - University of British Columbia. Microbiology and Immunology. 2009

Research

Dr. Cameron has >10 years' experience in microbiology research. His research interests include whole-genome sequencing and comparative genomics of bacterial pathogens. He is currently involved in whole-genome sequencing of SARS-CoV-2.
Dr. Cameron has >10 years' experience in microbiology research. His research interests include whole-genome sequencing and comparative genomics of bacterial pathogens. He is currently involved in whole-genome sequencing of SARS-CoV-2.

Publications

Journal Articles

IgG Against Human Betacoronavirus Spike Proteins Correlates With SARS-CoV-2 Anti-Spike IgG Responses and COVID-19 Disease Severity.

Wang J, Li D, Cameron A, Zhou Q, Wiltse A, Nayak J, Pecora ND, Zand MS

The Journal of infectious diseases.. 2022 August 26226 (3):474-484. Epub 1900 01 01.

Simultaneous Measurement of IgM and IgG Antibodies to SARS-CoV-2 Spike, RBD, and Nucleocapsid Multiplexed in a Single Assay on the xMAP INTELLIFLEX DR-SE Flow Analyzer.

Cameron A, Bohrhunter JL, Porterfield CA, Mangat R, Karasick MH, Pearson Z, Angeloni S, Pecora ND

Microbiology spectrum.. 2022 April 2710 (2):e0250721. Epub 04/07/2022.

Painful Purulent Nodules Caused by Mycobacterium at Site of Lipodissolve Injections.

Kaur H, Reyes-Barron C, Sipprell WH, Cameron A, Louie T, Tsai PR, Scott G

The American Journal of dermatopathology.. 2022 April 144 (4):257-259. Epub 1900 01 01.

Human Disease Caused by Kalamiella piersonii

Alpizar-Rivas, R.; Cameron, A.; Hay, C.

IMClinicalCases. 2022; 1(e210220).

Detection of CTX-M-27 ?-Lactamase Genes on Two Distinct Plasmid Types in ST38 Escherichia coli from Three U.S. States.

Cameron A, Mangat R, Taffner S, Wang J, Dumyati G, Stanton RA, Daniels JB, Campbell D, Lutgring JD, Pecora ND

Antimicrobial agents and chemotherapy.. 2021 June 1765 (7):e0082521. Epub 06/17/2021.

A Rapid, Multiplex Dual Reporter IgG and IgM SARS-CoV-2 Neutralization Assay for a Multiplexed Bead-Based Flow Analysis System.

Angeloni S, Cameron A, Pecora ND, Dunbar S

Journal of visualized experiments : JoVE.. 2021 April 6 (170)Epub 04/06/2021.

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories.

Zhang YV, Wiencek J, Meng QH, Theel ES, Babic N, Sepiashvili L, Pecora ND, Slev P, Cameron A, Konforte D,

Clinical chemistry.. 2021 March 24 Epub 03/24/2021.

A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.

Cameron A, Porterfield CA, Byron LD, Wang J, Pearson Z, Bohrhunter JL, Cardillo AB, Ryan-Muntz L, Sorensen RA, Caserta MT, Angeloni S, Hardy DJ, Zand MS, Pecora ND

Journal of clinical microbiology.. 2021 January 2159 (2)Epub 01/21/2021.

Clinical Pathogen Genomics.

Cameron A, Bohrhunter JL, Taffner S, Malek A, Pecora ND

Clinics in laboratory medicine.. 2020 December 40 (4):447-458. Epub 10/01/2020.

Surveillance of Enterococcus spp. reveals distinct species and antimicrobial resistance diversity across a One-Health continuum.

Zaheer R, Cook SR, Barbieri R, Goji N, Cameron A, Petkau A, Polo RO, Tymensen L, Stamm C, Song J, Hannon S, Jones T, Church D, Booker CW, Amoako K, Van Domselaar G, Read RR, McAllister TA

Scientific reports.. 2020 March 310 (1):3937. Epub 03/03/2020.

Genomic Surveillance of Ceftriaxone-Resistant in Western New York Suggests the Extended-Spectrum ?-Lactamase Is Emerging on Distinct Plasmids in ST38.

Mostafa HH, Cameron A, Taffner SM, Wang J, Malek A, Dumyati G, Hardy DJ, Pecora ND

Frontiers in microbiology.. 2020 11 :1747. Epub 07/30/2020.

Could probiotics be the panacea alternative to the use of antimicrobials in livestock diets?

Cameron A, McAllister TA

Beneficial microbes.. 2019 October 1410 (7):773-799. Epub 08/27/2019.

Invited review: Application of meta-omics to understand the dynamic nature of the rumen microbiome and how it responds to diet in ruminants.

Gruninger RJ, Ribeiro GO, Cameron A, McAllister TA

Animal : an international journal of animal bioscience.. 2019 September 13 (9):1843-1854. Epub 05/07/2019.

Bacteriocin Occurrence and Activity in Isolated from Bovines and Wastewater.

Cameron A, Zaheer R, Adator EH, Barbieri R, Reuter T, McAllister TA

Toxins.. 2019 August 1511 (8)Epub 08/15/2019.

Functional screening for triclosan resistance in a wastewater metagenome and isolates of Escherichia coli and Enterococcus spp. from a large Canadian healthcare region.

Cameron A, Barbieri R, Read R, Church D, Adator EH, Zaheer R, McAllister TA

PloS one.. 2019 14 (1):e0211144. Epub 01/24/2019.

A Novel Aminoglycoside Resistance Gene in Bovine and Porcine Pathogens.

Cameron A, Klima CL, Ha R, Gruninger RJ, Zaheer R, McAllister TA

mSphere.. 2018 3 (1)Epub 02/28/2018.

Antimicrobial usage and resistance in beef production.

Cameron A, McAllister TA

Journal of animal science and biotechnology.. 2016 7 :68. Epub 12/12/2016.

High-Frequency Variation of Purine Biosynthesis Genes Is a Mechanism of Success in Campylobacter jejuni.

Cameron A, Huynh S, Scott NE, Frirdich E, Apel D, Foster LJ, Parker CT, Gaynor EC

mBio.. 2015 September 296 (5):e00612-15. Epub 09/29/2015.

Hygromycin B and apramycin antibiotic resistance cassettes for use in Campylobacter jejuni.

Cameron A, Gaynor EC

PloS one.. 2014 9 (4):e95084. Epub 04/21/2014.

Hyperosmotic stress response of Campylobacter jejuni.

Cameron A, Frirdich E, Huynh S, Parker CT, Gaynor EC

Journal of bacteriology.. 2012 November 194 (22):6116-30. Epub 09/07/2012.

Effects of sequential Campylobacter jejuni 81-176 lipooligosaccharide core truncations on biofilm formation, stress survival, and pathogenesis.

Naito M, Frirdich E, Fields JA, Pryjma M, Li J, Cameron A, Gilbert M, Thompson SA, Gaynor EC

Journal of bacteriology.. 2010 April 192 (8):2182-92. Epub 02/05/2010.